After-Hours Gainers: ALXO, GMED, ACRV, And Biotech Peers Rally On Trial Data And Earnings Updates

Several biotechnology and healthcare companies posted notable gains in after-hours trading on Wednesday, driven by clinical updates, financial results, and upcoming industry presentations.ALX Oncology Holdings Inc. (ALXO) surged 10.17% to $1.30 after announcing positive data from a Phase 2 investigator-sponsored trial of its lead candidate, evorpacept. The therapy, combined with rituximab and lenalidomide, showed promise in patients with indolent B-cell non-Hodgkin lymphoma. The findings are scheduled to b ...